case_images: PMC10987708_01
case_images: PMC10987708_02
case_images: Overview of hemoglobin in g/dL of patient 1 before, during and after the inpatient stays for autoimmune hemolytic anemia (AIHA) (in February/March and September 2022) over a total period of one year. RBC, red blood cell concentrate.
case_images: fimmu-15-1342845-g001.jpg
case_images: PMC10987708_02_fimmu-15-1342845-g001.jpg
case_images: f1
case_images: Due to progression of disease in December 2021 systemic treatment with ipilimumab (3 mg/kg) and nivolumab (1mg/kg) every three weeks was re-initiated ( Figure 1 ).
case_images: PMC10987708_03
case_images: PMC10987708_04
case_images: PMC10987708_05
case_images: PMC10987708_06
case_images: Overview of the hemoglobin in g/dL of patient 2 before, during and after the inpatient stay for autoimmune hemolytic anemia (AIHA) over a total period of three months.
case_images: fimmu-15-1342845-g002.jpg
case_images: PMC10987708_06_fimmu-15-1342845-g002.jpg
case_images: f2
case_images: Thus we initiated an adjuvant therapy with pembrolizumab 400 mg every six weeks and radiotherapy of lymph node metastases in August 2022 ( Figure 2 ).
case_images: Overview of troponin T in ng/mL and NT-pro-BNP in pg/mL of patient 2 during and after the inpatient stay over a total period of ten weeks. First measurement of troponin T and NT-pro-BNP on 14th of September 2022.
case_images: fimmu-15-1342845-g003.jpg
case_images: PMC10987708_06_fimmu-15-1342845-g003.jpg
case_images: f3
case_images: Because of the initial cardiac symptoms, N-terminal pro B-type natriuretic peptide (NT-proBNP) and troponin T levels were also taken, revealing an elevated NT-pro-BNP of 912 pg/mL and increased troponin T of 110 ng/mL, the latter, however, was found stable at 117.ng/mL after one hour ( Figure 3 ).
case_images: PMC10987708_07